Skip Navigation

A Phase II Study of the Safety, Tolerability, and Efficacy of INCB050465 in Combination With Ruxolitinib in Subjects with Myelofibrosis

Brief Summary

Type:
Myelofibrosis

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT02718300

Study #:
STUDY00140515

Start Date:
May 04, 2017

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02718300

View Complete Trial Details & Eligibility at ClinicalTrials.gov